Literature DB >> 3988959

Serum C-reactive protein concentration in the management of infection in patients treated by continuous ambulatory peritoneal dialysis.

C R Hind, S P Thomson, C G Winearls, M B Pepys.   

Abstract

In a prospective study over 21 months, serum C-reactive protein (CRP) concentration was measured serially in 39 consecutive patients undergoing continuous ambulatory peritoneal dialysis. All patients with peritonitis mounted a CRP response, and the height of the response correlated well with the severity and extent of the peritoneal damage. Patients who recovered uneventfully after antimicrobial treatment showed a prompt fall in CRP from its peak value towards normal. In contrast, each patient in whom the serum CRP value remained raised after antimicrobial treatment had a complicated course. During routine outpatient follow up the serum CRP value remained within the normal range in the absence of intercurrent complications. These results, together with the commercial availability of rapid and precise assays for CRP, indicate that serial CRP measurements may be useful in monitoring the efficacy of antimicrobial treatment during episodes of peritonitis and in the recognition of intercurrent complications in patients undergoing continuous ambulatory peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988959      PMCID: PMC499179          DOI: 10.1136/jcp.38.4.459

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration.

Authors:  C R Hind; C O Savage; C G Winearls; M B Pepys
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

2.  Carnitine, clue or cure?

Authors: 
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

3.  Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report.

Authors:  J Mertin; P Rudge; M Kremer; M J Healey; S C Knight; A Compston; J R Batchelor; E J Thompson; A M Halliday; M Denman; P B Medawar
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

Review 4.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

5.  Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Authors:  E A Fagan; R F Dyck; P N Maton; H J Hodgson; V S Chadwick; A Petrie; M B Pepys
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

6.  C-reactive protein for rapid monitoring of infections of the central nervous system.

Authors:  H O Peltola
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

7.  Continuous ambulatory peritoneal dialysis: three years' experience.

Authors:  J M Ramos; R Gokal; K Siamopolous; M K Ward; R Wilkinson; D N Kerr
Journal:  Q J Med       Date:  1983

8.  Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.

Authors:  R K Mallya; F C de Beer; H Berry; E D Hamilton; B E Mace; M B Pepys
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

9.  Solid phase radioimmunoassays for human C-reactive protein.

Authors:  B Shine; F C de Beer; M B Pepys
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

10.  C-reactive protein (CRP) in early diagnosis of neonatal septicemia.

Authors:  K G Sabel; C Wadsworth
Journal:  Acta Paediatr Scand       Date:  1979-11
View more
  4 in total

1.  Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.

Authors:  Mark B Pepys; Philip N Hawkins; Melvyn C Kahan; Glenys A Tennent; J Ruth Gallimore; David Graham; Caroline A Sabin; Arturo Zychlinsky; Juana de Diego
Journal:  Circ Res       Date:  2005-10-27       Impact factor: 17.367

2.  Long Non-Coding RNA MALAT1 Promotes Acute Cerebral Infarction Through miRNAs-Mediated hs-CRP Regulation.

Authors:  Lili Teng; Ruifeng Meng
Journal:  J Mol Neurosci       Date:  2019-07-24       Impact factor: 3.444

3.  C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients.

Authors:  P C Ligtenberg; I M Hoepelman; G A Oude Sogtoen; A W Dekker; I van der Tweel; M Rozenberg-Arska; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

4.  Risk Factors and Pathogen Spectrum in Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis: A Single Center Retrospective Study.

Authors:  Supei Yin; Ming Tang; Zhengsheng Rao; Ximing Chen; Mengjuan Zhang; Ling Liu; Keqin Zhang
Journal:  Med Sci Monit       Date:  2022-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.